Asian markets opened higher amid positive global cues. Last checked, Japan's Nikkei 225 index was trading 0.42 per cent ...

Track top stocks like Tata Motors, IndusInd Bank, Kaynes Tech, and more as key updates and earnings could drive action ...

Key stocks to watch on August 5 include DLF, Aurobindo Pharma, LTIMindtree, Sona BLW, Paytm, and more, following key earnings ...

Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...

AUROBINDO PHARMA LTD - Corporate Action-Board approves Dividend - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts ...

Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT, citing API sales and US market revenue decline. The company's ...

A record date is set by the company to determine which shareholders are eligible to receive the dividend. If your name is on ...

Mumbai: Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Aurobindo Pharma reports a 10% decline in consolidated net profit to Rs 824 crore for the June quarter, due to dwindling ...

Aurobindo Pharma Ltd. announced on Monday an interim dividend of Rs 4 per equity share with a face value of Re 1 for the ...

Aurobindo Pharma reports 10% decline in Q1 net profit to Rs 824 crore due to lower US sales. Revenue rises to Rs 7,868 crore.

Aurobindo Pharma's revenue increased by 4% year-on-year for the three months ended June, reaching Rs 7,868 crore.